×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PACB – pacific biosciences of california, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PACB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/4
07:13 am
pacb
Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB) [Yahoo! Finance]
Low
Report
Life Sciences Tools & Services Stocks Q4 Recap: Benchmarking PacBio (NASDAQ:PACB) [Yahoo! Finance]
2/27
07:25 pm
pacb
PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know [Yahoo! Finance]
Medium
Report
PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know [Yahoo! Finance]
2/24
09:41 am
pacb
PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research [Yahoo! Finance]
Medium
Report
PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research [Yahoo! Finance]
2/24
09:05 am
pacb
PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research
Medium
Report
PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research
2/22
11:50 pm
pacb
Why The PacBio (PACB) Narrative Is Shifting Around Fair Value And Long Read Sequencing [Yahoo! Finance]
Medium
Report
Why The PacBio (PACB) Narrative Is Shifting Around Fair Value And Long Read Sequencing [Yahoo! Finance]
2/21
06:31 am
pacb
Pacific Biosciences of California (NASDAQ:PACB) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Medium
Report
Pacific Biosciences of California (NASDAQ:PACB) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
2/18
04:37 pm
pacb
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/18
04:05 pm
pacb
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference
Low
Report
PacBio to Participate in the TD Cowen 46th Annual Health Care Conference
Date
Time
Symbol
Company Name
Action
%Chg
2/12/2026
04:05 pm
pacb
pacific biosciences of california, inc.
BEAT
Report
-7.1%
pacific biosciences of california, inc.
11/5/2025
04:02 pm
pacb
pacific biosciences of california, inc.
BEAT
Report
-7.8%
pacific biosciences of california, inc.
8/7/2025
04:05 pm
pacb
pacific biosciences of california, inc.
BEAT
Report
7.1%
pacific biosciences of california, inc.
5/8/2025
04:15 pm
pacb
pacific biosciences of california, inc.
BEAT
Report
-7.3%
pacific biosciences of california, inc.
Date
Time
Symbol
Headline
Impact
3/3
06:16 pm
pacb
Form 4 PACIFIC BIOSCIENCES OF For: Feb 27 Filed by: Farmer Michele
Medium
Report
Form 4 PACIFIC BIOSCIENCES OF For: Feb 27 Filed by: Farmer Michele
3/3
06:15 pm
pacb
Form 4 PACIFIC BIOSCIENCES OF For: Feb 27 Filed by: Gibson James R II
Medium
Report
Form 4 PACIFIC BIOSCIENCES OF For: Feb 27 Filed by: Gibson James R II
3/3
06:13 pm
pacb
Form 4 PACIFIC BIOSCIENCES OF For: Feb 27 Filed by: Van Oene Mark
Medium
Report
Form 4 PACIFIC BIOSCIENCES OF For: Feb 27 Filed by: Van Oene Mark
3/3
06:11 pm
pacb
Form 4 PACIFIC BIOSCIENCES OF For: Feb 27 Filed by: HENRY CHRISTIAN O
Medium
Report
Form 4 PACIFIC BIOSCIENCES OF For: Feb 27 Filed by: HENRY CHRISTIAN O
3/3
04:30 pm
pacb
Form 144 PACIFIC BIOSCIENCES OF Filed by: Van Oene Mark
Low
Report
Form 144 PACIFIC BIOSCIENCES OF Filed by: Van Oene Mark
3/3
04:30 pm
pacb
Form 144 PACIFIC BIOSCIENCES OF Filed by: HENRY CHRISTIAN O
Low
Report
Form 144 PACIFIC BIOSCIENCES OF Filed by: HENRY CHRISTIAN O
2/25
04:42 pm
pacb
Form S-3ASR PACIFIC BIOSCIENCES OF
Medium
Report
Form S-3ASR PACIFIC BIOSCIENCES OF
2/25
04:17 pm
pacb
Form S-8 PACIFIC BIOSCIENCES OF
Medium
Report
Form S-8 PACIFIC BIOSCIENCES OF
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/18
Pacific Biosciences down 19% after patent ruling [Seeking Alpha]
14.8%
3/16 Form 4 PACIFIC BIOSCIENCES OF For: Mar 16 Filed by: HENRY CHRISTIAN O 13.3%
3/24 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 8.5%
4/28 Form DEF 14A PACIFIC BIOSCIENCES OF For: Apr 28 7.9%
3/5 Christian Henry Appointed Chairman of Pacific Biosciences’ Board of Directors 6.5%
4/8 Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs 5.3%
10/15 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at Piper Jaffray Companies from a "neutral" rating to an "overweight" rating. 5.1%
6/18 Form 8-K PACIFIC BIOSCIENCES OF For: Jun 18 4.9%
2/27 Pacific Biosciences of California (NASDAQ: PACB) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 3.5%
4/2 Form 3 PACIFIC BIOSCIENCES OF For: Apr 01 Filed by: Zaccarin Denis 3.4%
3/16 Form 4 PACIFIC BIOSCIENCES OF For: Mar 16 Filed by: HENRY CHRISTIAN O 13.3%
3/24 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 8.5%
4/28 Form DEF 14A PACIFIC BIOSCIENCES OF For: Apr 28 7.9%
3/5 Christian Henry Appointed Chairman of Pacific Biosciences’ Board of Directors 6.5%
4/8 Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs 5.3%
10/15 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at Piper Jaffray Companies from a "neutral" rating to an "overweight" rating. 5.1%
6/18 Form 8-K PACIFIC BIOSCIENCES OF For: Jun 18 4.9%
2/27 Pacific Biosciences of California (NASDAQ: PACB) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 3.5%
4/2 Form 3 PACIFIC BIOSCIENCES OF For: Apr 01 Filed by: Zaccarin Denis 3.4%
TOP News Decliners
2/6
Pacific Biosciences of California, Inc. (PACB) CEO Mike Hunkapiller on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha]
-11.6%
2/10 Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: BlackRock Inc. -9.9%
2/25 Form 4 PACIFIC BIOSCIENCES OF For: Feb 19 Filed by: BARNES SUSAN K -9.9%
2/20 Form 4 PACIFIC BIOSCIENCES OF For: Feb 18 Filed by: BARNES SUSAN K -6.5%
8/13 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.3%
2/24 Form 4 PACIFIC BIOSCIENCES OF For: Feb 20 Filed by: Hunkapiller Michael -5.1%
12/16 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.9%
11/7 Q3/2019 9/30/2019 EPS -0.190 ZacksConsensus -0.140 ActVsEst (0.050) - Miss -3.7%
11/4 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -2.4%
9/26 Form 8-K PACIFIC BIOSCIENCES OF For: Sep 25 -2.3%
2/10 Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: BlackRock Inc. -9.9%
2/25 Form 4 PACIFIC BIOSCIENCES OF For: Feb 19 Filed by: BARNES SUSAN K -9.9%
2/20 Form 4 PACIFIC BIOSCIENCES OF For: Feb 18 Filed by: BARNES SUSAN K -6.5%
8/13 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.3%
2/24 Form 4 PACIFIC BIOSCIENCES OF For: Feb 20 Filed by: Hunkapiller Michael -5.1%
12/16 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.9%
11/7 Q3/2019 9/30/2019 EPS -0.190 ZacksConsensus -0.140 ActVsEst (0.050) - Miss -3.7%
11/4 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -2.4%
9/26 Form 8-K PACIFIC BIOSCIENCES OF For: Sep 25 -2.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: